Adverse events even after percutaneous coronary intervention: is there any way to predict it?
- PMID: 20040008
- DOI: 10.1111/j.1540-8183.2009.00514.x
Adverse events even after percutaneous coronary intervention: is there any way to predict it?
Abstract
Since its development, the frequency and indication of percutaneous coronary intervention (PCI) have been increasing tremendously. Although generally the procedure shows promising results, some patients still develop cardiovascular events even after PCI. Some risk prediction models have been developed in order to identify this group of patients who possess higher risk of developing cardiovascular events after PCI. This article discusses the available risk prediction models, the difference between risk prediction models, choosing risk prediction models, and also limitations of the available risk prediction models.
Similar articles
-
Development and validation of a risk scoring model to predict net adverse cardiovascular outcomes after primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: rationale and design of the RISK-PCI study.J Interv Cardiol. 2009 Aug;22(4):320-8. doi: 10.1111/j.1540-8183.2009.00476.x. Epub 2009 Jun 8. J Interv Cardiol. 2009. PMID: 19515084
-
Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.J Interv Cardiol. 2007 Feb;20(1):10-6. doi: 10.1111/j.1540-8183.2007.00222.x. J Interv Cardiol. 2007. PMID: 17300391
-
Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Clin Ther. 2008. PMID: 19281914 Review.
-
Predicting major adverse cardiac events after percutaneous coronary intervention: the Texas Heart Institute risk score.Am Heart J. 2008 Jun;155(6):1068-74. doi: 10.1016/j.ahj.2008.01.034. Epub 2008 Apr 3. Am Heart J. 2008. PMID: 18513521
-
Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.Minerva Cardioangiol. 2003 Oct;51(5):585-97. Minerva Cardioangiol. 2003. PMID: 14551526 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous